The company's purpose is to operate medical practices, particularly in the field of autologous cell transplantation for the regeneration of degenerative and inflammatory changes in organs derived from mesenchymal embryonic tissue of the human body, within the framework of physiological aging, illness or accident. The company may enter into any business and conclude contracts that are suitable to promote the purpose of the company or that are directly or indirectly related to it. The company may acquire, encumber, manage and dispose of real estate and securities. It may take out loans and grant them, provide guarantees and other securities, acquire, manage and exploit intellectual property rights. Furthermore, it may establish branches and subsidiaries in Switzerland and abroad, participate in other companies or merge with them.